Skip to main content
Erschienen in: International Journal of Public Health 1/2020

25.06.2019 | Original article

Diabetes mellitus and treatment outcomes of pulmonary tuberculosis: a cohort study

verfasst von: Serine Sahakyan, Varduhi Petrosyan, Lusine Abrahamyan

Erschienen in: International Journal of Public Health | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Objectives

This study aimed to investigate the impact of diabetes on the treatment outcomes among pulmonary TB patients in Yerevan, Armenia.

Methods

We utilized a cohort study design that included TB patients with diabetes and TB patients without diabetes. The data collection was conducted in the National Tuberculosis Control Center, eight tuberculosis outpatient centers and the ‘Prisoners’ Hospital’ in Yerevan, Armenia. Data were collected from an existing national TB database and patients medical records. Multivariable logistic regressions were conducted to construct the final model and test the associations.

Results

The final sample included 621 patients 5.8% of whom had diabetes. The odds of having treatment failure was 8.99 times higher among TB patients with diabetes (95% confidence interval 2.51–32.23) compared to TB patients without diabetes after adjusting for weight and sputum smear status.

Conclusions

Diabetes comorbidity had a negative effect on TB treatment outcomes. Countries with a high burden of both TB and diabetes need to develop mechanisms for active screening for diabetes among patients with TB and address their treatment needs carefully.
Literatur
Zurück zum Zitat Alisjahbana B, van Crevel R, Sahiratmadja E, den Heijer M, Maya A, Istriana E, van der Meer JW (2006) Diabetes mellitus is strongly associated with tuberculosis in Indonesia. Int J Tuberc Lung Dis Off J Int Union Against Tuberc Lung Dis 10(6):696–700 Alisjahbana B, van Crevel R, Sahiratmadja E, den Heijer M, Maya A, Istriana E, van der Meer JW (2006) Diabetes mellitus is strongly associated with tuberculosis in Indonesia. Int J Tuberc Lung Dis Off J Int Union Against Tuberc Lung Dis 10(6):696–700
Zurück zum Zitat Alisjahbana B, Sahiratmadja E, Nelwan EJ, Purwa AM, Ahmad Y, Ottenhoff THM, van Crevel R (2007) The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis Off Publ Infect Dis Soc Am 45(4):428–435. https://doi.org/10.1086/519841 CrossRef Alisjahbana B, Sahiratmadja E, Nelwan EJ, Purwa AM, Ahmad Y, Ottenhoff THM, van Crevel R (2007) The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis Off Publ Infect Dis Soc Am 45(4):428–435. https://​doi.​org/​10.​1086/​519841 CrossRef
Zurück zum Zitat Andreasyan D, Bazarchyan Al, Manukyan S, Muradyan G, Torosyan A, Chamanyan A, Bidzyan L, Zelveyan P (2016) Health System Performance Assessment, Armenia. National Institute of Health named after academician S. Abdalbekyan, MoH, RA Andreasyan D, Bazarchyan Al, Manukyan S, Muradyan G, Torosyan A, Chamanyan A, Bidzyan L, Zelveyan P (2016) Health System Performance Assessment, Armenia. National Institute of Health named after academician S. Abdalbekyan, MoH, RA
Zurück zum Zitat Baldé NM, Camara A, Camara LM, Diallo MM, Kaké A, Bah-Sow OY (2006) Associated tuberculosis and diabetes in Conakry, Guinea: prevalence and clinical characteristics. Int J Tuberc Lung Dis Off J Int Union Against Tuberc Lung Dis 10(9):1036–1040 Baldé NM, Camara A, Camara LM, Diallo MM, Kaké A, Bah-Sow OY (2006) Associated tuberculosis and diabetes in Conakry, Guinea: prevalence and clinical characteristics. Int J Tuberc Lung Dis Off J Int Union Against Tuberc Lung Dis 10(9):1036–1040
Zurück zum Zitat Dooley KE, Tang T, Golub JE, Dorman SE, Cronin W (2009) Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg 80(4):634–639CrossRef Dooley KE, Tang T, Golub JE, Dorman SE, Cronin W (2009) Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis. Am J Trop Med Hyg 80(4):634–639CrossRef
Zurück zum Zitat European Centre for Disease Prevention and Control/WHO Regional Office for Europe (2013) Tuberculosis surveillance and monitoring in Europe 2013. European Centre for Disease Prevention and Control, Stockholm European Centre for Disease Prevention and Control/WHO Regional Office for Europe (2013) Tuberculosis surveillance and monitoring in Europe 2013. European Centre for Disease Prevention and Control, Stockholm
Zurück zum Zitat European Centre for Disease Prevention and Control/WHO Regional Office for Europe (2016) Tuberculosis surveillance and monitoring in Europe 2016. European Centre for Disease Prevention and Control, Stockholm European Centre for Disease Prevention and Control/WHO Regional Office for Europe (2016) Tuberculosis surveillance and monitoring in Europe 2016. European Centre for Disease Prevention and Control, Stockholm
Zurück zum Zitat Grigoryan R, Truzyan N, Martirosyan H, Crape B, Petrosyan V, Antonyan M (2008) Analysis of the TB Control System in Armenia in Both the Civilian and Penitentiary Sectors and Recommendations for Improvement: consultancy on reviewing the health system strengthening component of the TB Control in Prisons program in Armenia as part of the Hand-over Take-over Process review. American University of Armenia, Center for Health Services Research and Development, Yerevan, Armenia Grigoryan R, Truzyan N, Martirosyan H, Crape B, Petrosyan V, Antonyan M (2008) Analysis of the TB Control System in Armenia in Both the Civilian and Penitentiary Sectors and Recommendations for Improvement: consultancy on reviewing the health system strengthening component of the TB Control in Prisons program in Armenia as part of the Hand-over Take-over Process review. American University of Armenia, Center for Health Services Research and Development, Yerevan, Armenia
Zurück zum Zitat Mboussa J, Monabeka H, Kombo M, Yokolo D, Yoka-Mbio A, Yala F (2003) Course of pulmonary tuberculosis in diabetics. Rev Pneumol Clin 59(1):39–44PubMed Mboussa J, Monabeka H, Kombo M, Yokolo D, Yoka-Mbio A, Yala F (2003) Course of pulmonary tuberculosis in diabetics. Rev Pneumol Clin 59(1):39–44PubMed
Zurück zum Zitat Nijland HMJ, Ruslami R, Stalenhoef JE, Nelwan EJ, Alisjahbana B, Nelwan RHH, van Crevel R (2006) Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes. Clin Infect Dis Off Publ Infect Dis Soc Am 43(7):848–854. https://doi.org/10.1086/507543 CrossRef Nijland HMJ, Ruslami R, Stalenhoef JE, Nelwan EJ, Alisjahbana B, Nelwan RHH, van Crevel R (2006) Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes. Clin Infect Dis Off Publ Infect Dis Soc Am 43(7):848–854. https://​doi.​org/​10.​1086/​507543 CrossRef
Zurück zum Zitat Quy HT, Cobelens FG, Lan NT, Buu TN, Lambregts CS, Borgdorff MW (2006) Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis Off J Int Union Against Tuberc Lung Dis 10(1):45–51 Quy HT, Cobelens FG, Lan NT, Buu TN, Lambregts CS, Borgdorff MW (2006) Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis Off J Int Union Against Tuberc Lung Dis 10(1):45–51
Zurück zum Zitat Santha T, Garg R, Frieden TR, Chandrasekaran V, Subramani R, Gopi PG, Narayanan PR (2002) Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis (IJTLD) 6(May):780–788 Santha T, Garg R, Frieden TR, Chandrasekaran V, Subramani R, Gopi PG, Narayanan PR (2002) Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis (IJTLD) 6(May):780–788
Zurück zum Zitat Sterling TR, Zhao Z, Khan A, Chaisson RE, Schluger N, Mangura B, Vernon A (2006) Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors. Int J Tuberc Lung Dis Off J Int Union Against Tuberc Lung Dis 10(5):542–549 Sterling TR, Zhao Z, Khan A, Chaisson RE, Schluger N, Mangura B, Vernon A (2006) Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors. Int J Tuberc Lung Dis Off J Int Union Against Tuberc Lung Dis 10(5):542–549
Zurück zum Zitat Vorburger M (n.d.) Simple power calculations: how do we know we are doing them the right way. In: ASA Section on Survey Research Methods (Third) Vorburger M (n.d.) Simple power calculations: how do we know we are doing them the right way. In: ASA Section on Survey Research Methods (Third)
Metadaten
Titel
Diabetes mellitus and treatment outcomes of pulmonary tuberculosis: a cohort study
verfasst von
Serine Sahakyan
Varduhi Petrosyan
Lusine Abrahamyan
Publikationsdatum
25.06.2019
Verlag
Springer International Publishing
Erschienen in
International Journal of Public Health / Ausgabe 1/2020
Print ISSN: 1661-8556
Elektronische ISSN: 1661-8564
DOI
https://doi.org/10.1007/s00038-019-01277-2

Weitere Artikel der Ausgabe 1/2020

International Journal of Public Health 1/2020 Zur Ausgabe